GBIO: Generation Bio Quarterly Revenue Growth

GBIO (Generation Bio Corp) - company brandmark

Generation Bio Co. (GBIO) aims for global leadership in the non-viral drug segment through the expansion of its ceDNA platform and B2B partnerships. A team of top geneticists is developing breakthrough treatments backed by significant investments. The quarterly revenue growth rate illustrates the impact of these factors, where -79.50 captures the current state of the parameter. However, the lack of commercial revenue and the current testing stage create a high dependency on scientific potential.

GBIO (Generation Bio Co.) Quarterly Sales Growth Rate history from 07/04/2022 to 02/21/2026

Analytical breakdowns for Generation Bio Corp (GBIO)

- share price and expert price forecast:
Initial company analysis:GBIO - generationbio.com
Flagship merchandise of Generation Bio Co

This indicator captures the percentage change in sales volume for the current quarter relative to the previous one, allowing for a quantitative assessment of business expansion speed and the impact of market demand. Analyzing the quarterly revenue growth rate is critical for Generation Bio Co. (GBIO), as the scalability of their universal gene platform must translate into rapid growth in licensing fees and royalties while maintaining low operating expenses.

Main competitors

TEM - Revenue Growth QoQ|Quarterly Sales Growth Rate qiagen.com QGEN|IONS: Quarterly Revenue Growth|Repligen Corp - Quarterly Revenue Increase|RNA (Avidity Corp) - Quarterly Revenue Growth|CRISPR Therapeutics Corp - Revenue Dynamics QoQ|Revenue Growth QoQ genedx.com (WGS)|Quarterly Revenue Growth ultragenyx.com (RARE)|Quarterly Revenue Growth BEAM (Beam Therapeutics Inc)|Sarepta Therapeutics Inc (SRPT) - Quarterly Revenue Growth Rate|twistbioscience.com - Quarterly Revenue Growth|10x Genomics, Inc. - Sales Change QoQ|NTLA (Intellia Corp) - Quarterly Sales Growth|Quarterly Sales Growth stoketherapeutics.com|Quarterly Sales Growth BLFS|Quarterly Sales Growth Wave Life Sciences Corp (WVE)|Quarterly Revenue Growth MAZE|Quarterly Sales Growth Rate Sionna Therapeutics Inc|Revenue Growth QoQ Prime Medicine Corp PRME|tayshagtx.com (TSHA) - Quarterly Revenue Growth Rate|QURE - Revenue Growth QoQ|MeiraGTx Holdings (MGTX) - Quarterly Sales Growth|Regenxbio (RGNX) - Revenue Growth QoQ|SLDB - Quarterly Sales Growth Rate|OCGN (Ocugen Inc) - Quarterly Revenue Growth|Revenue Growth QoQ PACB|Revenue Growth QoQ Benitec (BNTC)|Design Therapeutics Inc - Sales Growth QoQ|Revenue Growth QoQ Rocket Pharma RCKT|Quarterly Revenue Growth 4DMT FDMT|LXEO - Revenue Growth QoQ|Quarterly Revenue Growth Rate Korro Bio Inc.|EDIT: Quarterly Revenue Growth|SLN - Quarterly Sales Growth Rate|PRQR (ProQR Therapeutics) - Quarterly Revenue Growth|codexis.com (CDXS) - Quarterly Sales Growth Rate|Quarterly Revenue Growth SGMO|Quarterly Revenue Growth Nautilus Biotechnology, Inc. (NAUT)|Quarterly Revenue Growth MGX (Metagenomi Inc.)|Quarterly Revenue Increase DTIL|BOLD - Revenue Growth QoQ|Quarterly Sales Growth Rate Exicure Inc. XCUR|Imunon, Inc. (IMNN) - Revenue Growth QoQ|RXi Pharmaceuticals - Quarterly Revenue Increase|MBIO (Mustang Bio) - Quarterly Revenue Growth|Sales Growth QoQ RNAZ (transcodetherapeutics.com)|Revenue Growth QoQ Bionano (BNGO)|Applied DNA Sciences - Sales Growth QoQ|Quarterly Revenue Growth BLUE (bluebirdbio.com)|ImmunoPrecise Antibodies (IPA) - Quarterly Revenue Growth Rate|omegatherapeutics.com - Quarterly Revenue Growth|Revenue Change vs Previous Quarter Singular Genomics Systems Inc (OMIC)|RGLS: Quarterly Revenue Growth|Syros Pharmaceuticals, Inc (SYRS) - Quarterly Revenue Growth|TBIO (telesisbio.com) - Quarterly Revenue Growth|TCON: Quarterly Revenue Increase|Revenue Growth QoQ Unity Biotechnology, Inc (UBX)